Cipla

Cipla

Cipla - One of the Leading Global Pharmaceutical Companies in India, Cipla.

Launch date
Employees
Market cap
AUD28.1b
Enterprise valuation
AUD26.7b (Public information from Sep 2024)
Mumbai Maharashtra (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
INR2021202220232024202520262027
Revenues190.0b216.3b224.7b254.5b279.0b307.4b325.1b
% growth14 %14 %4 %13 %10 %10 %6 %
EBITDA44.4b47.1b55.0b66.9b70.2b78.1b78.3b
% EBITDA margin23 %22 %24 %26 %25 %25 %24 %
Profit24.0b25.2b28.0b41.2b47.0b52.8b53.1b
% profit margin13 %12 %12 %16 %17 %17 %16 %
EV / revenue3.5x3.8x3.2x4.5x4.5x4.0x3.7x
EV / EBITDA14.8x17.2x13.0x17.2x18.1x15.9x15.5x
R&D budget1.3b2.7b3.9b4.3b---
R&D % of revenue1 %1 %2 %2 %---

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
N/A

N/A

IPO
Total Funding-

Recent News about Cipla

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit

Investments by Cipla

Edit
Chase Pharmaceuticals
ACQUISITION by Allergan Nov 2016
Exelan Pharmaceuticals
ACQUISITION by Cipla Sep 2015
InvaGen Pharmaceuticals
ACQUISITION by Cipla Sep 2015
Mirren Pty
ACQUISITION by Cipla Jul 2018
Cipla Medpro South Africa
ACQUISITION by Cipla Jul 2013
Quality Chemicals
ACQUISITION by Cipla May 2015
Wellthy Therapeutics
ACQUISITION by TruDoc Feb 2024
View 1 more